Prosensa Holding (RNA) IPO Opens Sharply Higher – StreetInsider.com (subscription)

By Dr. Matthew Watson

Prosensa Holding (RNA) IPO Opens Sharply Higher
StreetInsider.com (subscription)
Prosensa Holding is an innovative biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company's primary focus is on rare ...
Prosensa leaps in 1st day of Nasdaq tradingThe Idaho Statesman

all 31 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFW63dhmZJa3SDxF7b7k92ytba9AA&url=http://www.streetinsider.com/Hot%2BIPOs/Prosensa%2BHolding%2B(RNA)%2BIPO%2BOpens%2BSharply%2BHigher/8459135.html



categoriaUncategorized commentoComments Off on Prosensa Holding (RNA) IPO Opens Sharply Higher – StreetInsider.com (subscription) | dataJune 30th, 2013

About...

This author published 5512 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.




Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024